4SC AG: 4SC Announces an Update to Resminostat's (Kinselby) Marketing Authorisation Application

Planegg-Martinsried (pta031/13.03.2025/16:15 UTC+1)

The Management Board of 4SC AG ("4SC") (Frankfurt Stock Exchange, Prime Standard: VSC; ISIN: DE000A3E5C40) resolved today that after having consulted with both the broader 4SC team, external experts and its Supervisory Board it will proceed to formulate a response to the EMA's Day-180 Assessment Report, and in particular to its major objections, and intends to file this with the EMA within the required deadline. 4SC now expects to receive feedback from the Committee for Medicinal Products for Human Use (CHMP) around the end of April 2025 and depending on the decision of the CHMP will then consider the future direction of the Company.

—————————————————————————
Information and Explanation of the Issuer to this News:

Forward-looking information

Information set forth in this press release contains forward-looking statements, which involve risks and uncertainties. The forward-looking statements contained herein represent the judgement of 4SC as of the date of this press release. Such forward-looking statements are neither promises nor guarantees, but are subject to a variety of risks and uncertainties, many of which are beyond 4SC's control, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. 4SC expressly disclaims any obligation or undertaking to release any updates or revisions to any such statements to reflect any change in its expectations or any change in events, conditions or circumstances on which any such statement is based.

For further information, please contact:

4SC AG
ir-pr@4sc.com

Optimum Strategic Communications
Nick Bastin, Vareen Outhonesack
Phone: +44 20 3922 0891
4SC@optimumcomms.com

(end)

Emitter:	4SC AG Fraunhoferstr. 22 82152 Planegg-Martinsried Germany
Contact Person:	Jason Loveridge
Phone:	+49 89 700763-0
E-Mail:	ir-pr@4sc.com
Website:	www.4sc.de
ISIN(s):	DE000A3E5C40 (Share)
Stock Exchange(s):	Regulated Market in Frankfurt; Free Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate